Volgen
Tommy B Andersson
Tommy B Andersson
DMPK, AstraZeneca R&D Gotheburg Sweden
Geverifieerd e-mailadres voor astrazeneca.com
Titel
Geciteerd door
Geciteerd door
Jaar
Membrane transporters in drug development
Nature reviews Drug discovery 9 (3), 215-236, 2010
36182010
Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities
XQ Li, TB Andersson, M Ahlström, L Weidolf
Drug metabolism and disposition 32 (8), 821-827, 2004
9742004
Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes
A Äbelö, TB Andersson, M Antonsson, AK Naudot, I Skånberg, L Weidolf
Drug Metabolism and Disposition 28 (8), 966-972, 2000
4982000
Pharmacokinetics, metabolism and interactions of acid pump inhibitors: focus on omeprazole, lansoprazole and pantoprazole
T Andersson
Clinical pharmacokinetics 31, 9-28, 1996
4731996
Physiological disturbances in fish living in coastal water polluted with bleached kraft pulp mill effluents
T Andersson, L Förlin, J Härdig, Å Larsson
Canadian Journal of Fisheries and Aquatic Sciences 45 (9), 1525-1536, 1988
4531988
Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies
KP Kanebratt, TB Andersson
Drug metabolism and disposition 36 (7), 1444-1452, 2008
4182008
Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis
A Kindmark, A Jawaid, CG Harbron, BJ Barratt, OF Bengtsson, ...
The pharmacogenomics journal 8 (3), 186-195, 2008
4102008
Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5′-upstream regulatory region
A Westlind, L Löfberg, N Tindberg, TB Andersson, M Ingelman-Sundberg
Biochemical and biophysical research communications 259 (1), 201-205, 1999
3981999
Regulation of the cytochrome P450 enzyme system in fish
T Andersson, L Förlin
Aquatic Toxicology 24 (1-2), 1-19, 1992
3771992
Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing
U Marx, TB Andersson, A Bahinski, M Beilmann, S Beken, FR Cassee, ...
Altex 33 (3), 272, 2016
3532016
Amodiaquine clearance and its metabolism ton-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate
XQ Li, A Björkman, TB Andersson, M Ridderström, CM Masimirembwa
Journal of Pharmacology and Experimental Therapeutics 300 (2), 399-407, 2002
3412002
Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism
A Westlind-Johnsson, S Malmebo, A Johansson, C Otter, TB Andersson, ...
Drug Metabolism and Disposition 31 (6), 755-761, 2003
3212003
Identification of human cytochrome P450s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data
XQ Li, A Björkman, TB Andersson, LL Gustafsson, CM Masimirembwa
European journal of clinical pharmacology 59, 429-442, 2003
2932003
The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human
TB Andersson, KP Kanebratt, JG Kenna
Expert opinion on drug metabolism & toxicology 8 (7), 909-920, 2012
2712012
Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43
A Westlind, S Malmebo, I Johansson, C Otter, TB Andersson, ...
Biochemical and biophysical research communications 281 (5), 1349-1355, 2001
2682001
Differential induction of cytochrome P-450-dependent monooxygenase, epoxide hydrolase, glutathione transferase and UDP glucuronosyl transferase activities in the liver of the …
T Andersson, M Pesonen, C Johansson
Biochemical pharmacology 34 (18), 3309-3314, 1985
2571985
Novel 3D culture systems for studies of human liver function and assessments of the hepatotoxicity of drugs and drug candidates
VM Lauschke, DFG Hendriks, CC Bell, TB Andersson, ...
Chemical research in toxicology 29 (12), 1936-1955, 2016
2552016
Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development
U Marx, T Akabane, TB Andersson, E Baker, M Beilmann, S Beken, ...
Altex 37 (3), 365, 2020
2542020
Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model
S Bauer, C Wennberg Huldt, KP Kanebratt, I Durieux, D Gunne, ...
Scientific reports 7 (1), 14620, 2017
2532017
HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans
KP Kanebratt, TB Andersson
Drug metabolism and disposition 36 (1), 137-145, 2008
2472008
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20